Latest Company Strategy News

Page 1 of 5
At its 2026 Annual Meeting, General Capital shareholders voted decisively against re-electing Managing Director Brent King, while approving a near 10% increase in the total director remuneration pool.
Claire Turing
Claire Turing
20 Aug 2026
PlaySide Studios reversed a prior-year loss with a 13% revenue increase to $54.9 million and a 144% jump in net profit to $5.4 million, driven by strong Original IP sales and a strategic cost restructure.
Sophie Babbage
Sophie Babbage
20 Aug 2026
Green Cross Health CEO Rachael Newfield will step down in January 2027 following the sale of the Medical division, paving the way for a new pharmacy-centric leadership role.
Ada Torres
Ada Torres
14 Aug 2026
Taiton Resources has finalised a placement of 1.14 million shares at 7 cents each, including shares and options issued to insiders following shareholder approval.
Maxwell Dee
Maxwell Dee
8 July 2026
Alice Queen Limited has pushed back the closing date for its partially underwritten rights issue to 19 June 2026, giving shareholders more time to subscribe at 0.9 cents per share.
Claire Turing
Claire Turing
9 June 2026
Alice Queen Limited has pushed back the closing date of its $5.77 million rights issue to 12 June 2026, giving shareholders more time to subscribe at 0.9 cents per share. The extension reflects the company's effort to maximise shareholder involvement ahead of the planned capital raise completion.
Claire Turing
Claire Turing
1 June 2026
BCAL Diagnostics appoints Anne-Louise Arnett as CEO effective June 2026, aiming to accelerate its commercial rollout and international market entry of early cancer detection tests.
Ada Torres
Ada Torres
11 May 2026
Nuix has appointed John Ruthven as its permanent CEO and Managing Director, ending a global search and signalling leadership continuity following his interim role since November 2025.
Sophie Babbage
Sophie Babbage
4 May 2026
Aguia Resources’ Brazilian subsidiary has achieved a key regulatory milestone with official fertiliser registration, enabling commercial sales of its PAMPAFOS phosphate product in Brazil’s large agricultural market.
Maxwell Dee
Maxwell Dee
8 Apr 2026
ImpediMed Limited has appointed Erik Anderson as its new CEO and Managing Director, effective 7 April 2026, aiming to boost commercial execution and revenue growth in the US market. Dr Parmjot Bains will remain as an advisor until 30 June 2026 to ensure a smooth leadership transition.
Ada Torres
Ada Torres
7 Apr 2026
Bougainville Copper Limited’s shares have been suspended from the ASX due to a late report lodgement, stirring investor concerns about compliance and transparency.
Maxwell Dee
Maxwell Dee
1 Apr 2026
CGN Resources has completed a detailed airborne magnetic survey over its Christmas Well Project in Western Australia, revealing multiple promising gold targets beneath shallow cover and setting the stage for imminent drilling.
Maxwell Dee
Maxwell Dee
9 Mar 2026

Browse the archive

Full archive